Heart disease, smoking, and air pollution deaths fall

Heart disease, smoking, and air pollution deaths fall
Heart valves. By OpenStax College - Anatomy & Physiology, Connexions Web site. http://cnx.org/content/col11496/1.6/, Jun 19, 2013., CC BY 3.0, Link

“The age-adjusted US death rate from ischemic heart disease, which is caused by blocked coronary arteries, fell 59 percent between 1990 and 2023,” notes The Doomslayer. The fall in coronary artery disease is partly due to reductions in smoking and air pollution — there have been “large declines in the mortality burden attributed to smoking and particulate air pollution.”

This is explained in a new analysis from the Global Burden of Disease study.

STAT reports that

Deaths due to ischemic heart disease — when coronary arteries are blocked — fell by more than half from 1990 to 2023 in the United States, thanks to better control of up to a dozen risk factors…

Much of the progress recorded since the start of the Global Burden of Disease study, published Wednesday in JAMA Cardiology, stemmed from drops in deaths from smoking (down 33.3%) and particulate air pollution (down 74.9%). But in the last year of the study, 419,000 of the estimated 473,000 coronary artery disease deaths — or 88.8% — were still linked to modifiable risk factors.

The warning signs for coronary artery disease in 2023 are familiar ones. Higher body mass index (up 12.5%) and higher blood glucose levels (10.5%) since 1990 are singled out as growing problems that align with greater prevalence of diabetes.

Artificial intelligence recently saved the life of a man with heart disease. A new, more durable artificial heart has been invented.

Scientists developed a patch of living cells that can repair damaged hearts.

A gene therapy cuts bad cholesterol and triglycerides, which could help prevent heart attacks.

A new drug reduces a mysterious particle linked to heart attack risk.

“Japanese regulators have conditionally approved two induced pluripotent stem cell therapies, one for Parkinson’s disease and another for heart failure, marking the first commercial approvals for the technology,” reported The Doomslayer.

Hans Bader

Hans Bader

Hans Bader practices law in Washington, D.C. After studying economics and history at the University of Virginia and law at Harvard, he practiced civil-rights, international-trade, and constitutional law. He also once worked in the Education Department. Hans writes for CNSNews.com and has appeared on C-SPAN’s “Washington Journal.” Contact him at hfb138@yahoo.com

Comments

For your convenience, you may leave commments below using Disqus. If Disqus is not appearing for you, please disable AdBlock to leave a comment.